Smart IT Solutions for Growth

Tailored IT services designed to maximise your ROI

About Us

Services

Get Dedicated Developers

Industry Solutions

Software Development

Web Design & Development

Mobile App Development

AI Development

eCommerce Development

CMS Development

CRM Software Development

Consulting Services

Build Your Dream Team Today!

Find skilled professionals, streamline collaboration, and scale your business effortlessly.

Director, IIH Global Limited

Generative AI in Life Sciences: Key Software Use Cases and Implementation Challenges

Life sciences companies need to speed up research, reduce development costs and meet strict regulations while ensuring their work remains accurate and reliable.

Generative AI for life sciences can help alleviate some of these pressures by enabling researchers to review scientific literature, organise research data, automate documentation and handle other complex tasks. However, turning these capabilities into a practical business application takes more than simply plugging in an AI model. It calls for the appropriate AI software for life sciences that can meet the application’s particular requirements and integrate with current workflows.

Both startups and established organisations must think about how to select the right use case, protect sensitive data and extend existing workflows. With suitable gen AI development services, companies can progress from prototyping to creating products that produce concrete results.

This guide addresses the technology, its applications, development costs, implementation, and the challenges to weigh before making an investment.

What Are the Capabilities of Generative AI in the Life Sciences?

Generative AI in the life sciences refers to a class of AI that can generate or summarise information, interpret data, and perform a variety of tasks throughout life science R & D, pharmaceutical discovery and development, clinical trial operations, and the sharing of scientific information. 

According to Fortune Business Insights, the market for generative AI in life sciences is poised for rapid growth, expected to be valued at $1.18 billion in 2025 and potentially reaching $18.20 billion by 2034. These figures represent projected revenues rather than the revenues of any single company.

The most powerful uses of generative AI lie in domains where life scientists today devote considerable time to looking up information, going through documents, or producing comparable outputs like reports or figures. Although AI could make these tasks faster and simpler, scientific and regulatory decisions frequently demand extra measures to guarantee accuracy and compliance.

What Is Generative AI in Life Sciences?

Generative AI in the life sciences is the application of AI models that can generate content, summarise and extract insights from scientific and clinical data sets. This can help researchers analyse publications, review clinical documents, report their own work and explore possible molecular structures.

In contrast to conventional analysis methods and software built for a set task, generative AI is able to respond to questions a user asks in natural language and deliver suitable answers.

For example, a biotechnology start-up could create an AI research assistant that can search through life science publications and report on relevant ones. However, the researcher would still need to assess the results before possibly using them to guide experiments and decision-making.

What Key Software Powers Generative AI in Life Sciences?

Building generative AI solutions for life sciences involves selecting the right software to manage scientific data, develop AI-powered features, connect existing systems and support secure deployment. The choice of AI software for life sciences depends on the intended application, whether it is a research assistant, a clinical documentation platform or a specialised drug discovery tool. 

1. AI Model Platforms

  • Tools including Azure AI Foundry, Amazon Bedrock and Google Vertex AI allow users to access, configure and use generative AI models in business applications.

2. Data Management Software

  • PostgreSQL, MongoDB, and vector databases serve to hold structured data, research documents, and information that supports AI applications. 

3. AI Development Frameworks

  • LangChain and LlamaIndex provide frameworks for connecting language models with company data, developing retrieval workflows and building AI-powered assistants.

4. Cloud and Application Development Platforms

  • Microsoft Azure, AWS, and Google Cloud offer the infrastructure needed to host AI applications, handle computing resources, and connect services with existing business systems. 

5. Security and Monitoring Software

  • Identity management, access control, logging and application monitoring tools protect sensitive information and track system behaviour. This is essential for applications that handle clinical, research, or proprietary data. 

The right software stack depends on the use case, existing systems, data sensitivity, scalability requirements and validation needs.

How to Implement Generative Artificial Intelligence in Life Sciences

Generative AI implementation starts with a defined business problem, not a model selection exercise. Take these steps to plan, build, and launch a solution that fits your business needs. 

Step 1: Define a measurable problem

  • Determine a process flow that might gain from a tool such as RAG or specialised models, for example, document analysis or searching research papers. Set your baseline and target for improvement.

Step 2: Evaluate data preparedness

  • Review data quality, ownership, accessibility, and sensitivity. Figure out whether you can make use of the information already available or if you need to prepare additional data. 

Step 3: Choose between existing models, RAG approaches and specialised models

  • Compare the possible approaches to the use case at hand. Avoid training your own models if possible, due to opportunity cost and complexity.

Step 4: Build a controlled prototype

  • Evaluate the approach with a sample that mirrors the data and tasks involved, verifying accuracy, source traceability, speed, usability and failure rates. 

Step 5: Validate security and performance requirements

  • Conduct tests for access controls, data processing, and behaviour and reliability of the method. In regulated scenarios, ensure all necessary evidence, documentation, and validation have been established before using. 

Step 6: Deploy gradually and measure impact

  • With a controlled group of users, test the result based on their reactions and performance, and if the application meets the minimum criteria, you can expand it. 

A staged approach to generative AI implementation gives leadership teams evidence to support further investment and limits the cost of scaling a solution that does not deliver.

How Generative AI Is Transforming Pharmaceutical Software

Generative AI is used in the pharmaceutical sector to enhance the efficiency of research and to assist with managing and organising scientific data along with the related documentation in drug development and clinical trial sectors.

Some of its key applications are:

Accelerate Life Sciences Innovation with Generative AI Simplify information-heavy workflows and develop AI-powered tools tailored to your research and operational needs.
  • Drug discovery: Summarisation and analysis of scientific literature to identify potential drug candidates. 
  • Clinical research: Clinical trial information organisation and reports writing assistance.
  • Regulatory documentation: Support the preparation, review and organisation of regulatory submission documents. 
  • Research data management: Support for searching and extracting information from scientific databases. 

Introducing artificial intelligence into pharmaceutical software allows for plugging the capabilities into the existing business processes and reducing routine work, automating information collection, and enabling faster access to relevant knowledge. However, the effectiveness of such technology improvements relies on proper data protection, integration into the existing system, and verification of outputs and validation procedures.

Bonus Read: Generative AI Developers: Skills Your Business Actually Needs

How Much Does Generative AI Software Cost in Life Sciences?

The cost depends on whether you need a focused AI assistant, a connected enterprise application or a specialised scientific platform. Developing enterprise GenAI solutions for life sciences may also involve additional work around data security, system integration and regulatory requirements.

The figures below are approximate development cost estimates in USD and may vary depending on project requirements, application complexity, features, integrations and ongoing maintenance.

Solution typeEstimated development costTypical scope
Proof of concept (PoC)$10,000–$30,000Test one use case with limited data and basic functionality
Minimum viable product (MVP)$30,000–$80,000Build a usable application with core features and initial integrations
Enterprise AI assistant$80,000–$200,000+Add permissions, internal data retrieval, monitoring and enterprise integrations
Specialised scientific AI platform$150,000–$500,000+Support complex data pipelines, specialised models, advanced validation and scientific workflows

Do, Checkout: AI Software Development: From Business Idea to Production Ready Product

What Are the Main Generative AI Use Cases in Life Sciences?

Generative AI is most useful when it helps life sciences teams solve specific problems, such as reviewing scientific literature, managing clinical documentation or supporting research. The right enterprise GenAI solutions should fit existing workflows and deliver measurable improvements rather than add complexity. 

1. Research and drug discovery

  • AI drug discovery pipelines can employ specific generative models to design possible candidate molecules, peptides, or compounds. These can be quickly evaluated alongside traditional computational and laboratory testing.

2. Clinical research and trial documentation

  • AI for clinical research purposes can generate protocols, summarise and extract information from documents, and perform literature research on the subject. At the same time, it is critical to ensure the accuracy of the results since errors can affect trial patients and the trial itself.

3. Scientific literature analysis

  • GenAI in life sciences can help researchers find relevant information in scientific literature databases, extract relevant details, and compare different documents. The ability to cite relevant articles is essential since finding supporting information is not enough to ensure accuracy.

4. Regulatory and medical writing

  • Generative AI applied to pharmaceuticals can help write, edit, and summarise scientific, regulatory, and medical documents. However, human oversight is required to ensure factual accuracy, proper terminology, and consistency with the source documents.

5. Laboratory and knowledge management

  • AI tools can assist laboratory workers in finding standard operating procedures, summarising experimental records, and searching for previous results and evidence. When used in tandem with laboratory management systems, such artificial intelligence can streamline repetitive knowledge searches while not eliminating the need for control.

6. Pharmacovigilance and safety information

  • AI in pharmaceutical software can be used to organise and summarise case narratives, extract information of interest and support safety documentation. The information still needs to be interpreted by human experts who evaluate the information and make decisions about what actions, if any, are required. 

The described use cases for generative AI in life sciences fall under different risk categories. The preparation of an internal summary for knowledge management presents much lower risks than the generation of information required for clinical or regulatory decision-making.

Also Read: Generative AI Integration: A Complete Enterprise Implementation Guide

Benefits of AI in Life Sciences

When applied to the right workflows, artificial intelligence in life sciences can provide a number of business benefits:

  • Enhanced information discovery: Assisting researchers in finding relevant evidence within large sets of documents.
  • Reduced repetitive work: Enabling automatic summarisation, document preparation and general information handling.
  • Improved knowledge access: More readily give access approved information to teams, enabling them to find and apply the information that they need.
  • More efficient research workflows: Allowing scientists to explore candidate hypotheses and structures earlier.
  • Improved operational consistency: Ensure consistent operational procedures are followed for the selected processes by defining workflows and review procedures.
  • More scalable digital capabilities: Building out the toolset that has been proven to work across teams.

What Challenges Can Businesses Face When Implementing GenAI?

The main challenges of GenAI in life sciences often involve data, reliability and governance rather than the model alone.

ChallengeHow to overcome it
Inaccurate outputsVerify AI responses against trusted sources and expert reviews.
Data exposureUse encryption, access controls and secure data handling.
Poor data qualityClean and validate data before integration.
Regulatory complianceDefine intended use and validate outputs appropriately.
Integration issuesPlan APIs and system compatibility early.
Unclear ROISet measurable goals and track results before scaling.

Also Read: Generative AI for Business: Benefits, Challenges & Emerging Trends

The Future of Generative AI in Life Sciences

The future of generative AI in life sciences will focus on specialised models that accelerate research and development and integrate more effectively with existing software. Applications in drug discovery, personalised medicine and clinical research can help teams innovate and make better-informed decisions. 

However, success depends on data quality, scientific rigour, regulatory requirements and human expertise. Businesses should invest in life sciences AI solutions that deliver measurable value while preparing to adopt promising technologies as they evolve. 

Ending Note

Generative AI in life sciences offers significant potential, but successful implementation depends on choosing the right application, preparing reliable data and validating outputs before deployment. Businesses should start with a specific use case, measure its results and expand only after demonstrating its value. This approach helps organisations adopt AI in healthcare and life sciences responsibly while maintaining data security, scientific accuracy and human oversight.

If you are planning a new product or modernising an existing platform, hire certified AI developers to help assess your requirements, estimate development costs and build a solution aligned with your business goals. IIH Global can help you move from an initial concept towards a practical implementation plan.

Share On :

Your Vision, Our Expertise –
Let’s Create Together

Discover Your Ideas With Us

Every innovative software product begins with simple conversations over coffee. Partner with the globally trusted software company that transforms your vision into reality.

Frequently Asked Questions

How is generative AI being used in life sciences?

What are the main generative AI use cases in life sciences?

How can generative AI support pharmaceutical software development?

What challenges do life sciences companies face when implementing GenAI?

How can businesses implement generative AI securely in life sciences?

Contact Us

Take the first step toward innovation—contact us now!

Ready to Transform Your Business?

Contact Our Experts Today!